Irregular ads on prescription drugs prohibited

Published: 2002-04-03 06:57:00

Updated: 2002-04-03 06:57:00

The Korea Food and Drug Administration (KFDA) has recently established a new clause designed to prohibit the irregular public advertisements of prescription drugs, such as anti-obesity drugs, hair growing agents and anti-impotence drugs, into the current enforcement regulations of the Pharmaceuti...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK